Governments of Canada and Saskatchewan Provide Funding for Agriculture Strategic Field Program Projects

May 05, 2022

Regina, Saskatchewan – Agriculture and Agri-Food Canada - The Governments of Canada and Saskatchewan have announced more than $484,000 for six projects through the Strategic Field Program (SFP) which offers funding for field level demonstrations and evaluation of targeted agriculture practices and technologies.

The SFP funding supports field-level demonstrations and research that are relevant to agriculture producers, such as studying the effect of dugout aeration on greenhouse gas emissions and the use of virtual fencing on forested pasture.

The development of project proposals and applications for the SFP is led by Saskatchewan Ministry of Agriculture specialists. Funding is awarded on an annual basis. Successful projects in 2022 will be conducted by University of Regina, University of Saskatchewan, South East Research Farm, Judd Street Associates-Crops Consulting Services, Spencer Horticultural Solutions and the Saskatchewan Stock Growers Association.

Source : canada.ca

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.